Bio-Gene’s CEO Richard Jagger commented: “Whilst we understand...

Bio-Gene’s CEO Richard Jagger commented: “Whilst we understand Virbac is unlikely to progress its testing, Bio- Gene is continuing its wider research program of its platform technology for control of buffalo flies and ticks. As part of that program, Purdue University has already started a study on FlavocideTM efficacy on ticks, and the early data is showing evidence that this molecule has the potential to control ticks, and specifically resistant populations of ticks and flies.

“In addition to the work being undertaken by Purdue University, we also have various other evaluation programs underway exploring efficacy on a wide range of crop pests, grain storage pests, public health vectors and consumer pest applications. Results from these programs are expected over the coming weeks and months. The testing regime continues as quickly as possible, encouraged by continuing results across a range of pests and in particular against those demonstrating resistance to current insecticides.